Table 1. Clinical Chracteristics of 81 Study Patients.
| Characteristics | Value |
|---|---|
| Age (years) | |
| Mean ± SD | 57.5 ± 10.8 |
| Sex, n (%) | |
| Males | 65 (80.25) |
| Females | 16 (19.75) |
| Etiology of liver cirrhosis, n (%) | |
| HBV-related | 60 (74.07) |
| HCV-related | 7 (8.64) |
| Alcoholic | 3 (3.70) |
| Others | 11 (13.58) |
| Child-Pugh score, n (%) | |
| 5 | 78 (96.30) |
| 6 | 2 (2.47) |
| 7 | 1 (1.23) |
| BCLC staging, n (%) | |
| 0 | 8 (9.88) |
| A | 73 (90.12) |
| Size | |
| Mean ± SD | 5.24 ± 3.71 |
| Microscopic vascular invasion, n (%) | |
| Yes | 29 (35.80) |
| No | 52 (64.20) |
| Histologic grade, n (%) | |
| 1 | 3 (3.70) |
| 2 | 49 (60.49) |
| 3 | 27 (33.33) |
| 4 | 2 (2.47) |
| Serum AFP level (ng/mL) | |
| Mean ± SD | 3324.30 ± 15000.84 |
| Serum PIVKA-II level (ng/mL) | |
| Mean ± SD | 5615.10 ± 14798.72 |
Continuous data expressed as mean ± SD. AFP = alpha-fetoprotein, BCLC = Barcelona Clinic Liver Cancer staging, HBV = hepatitis B virus, HCV = hepatitis C virus, PIVKA-II = vitamin K absence or antagonist-II, SD = standard deviation